Trial Profile
Prospective, observational randomised study evaluating effectiveness and safety of Botulinum Toxin type-A for Chronic Focal Post-Stroke Upper limb Spasticity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders